2020
DOI: 10.3390/antiox9100994
|View full text |Cite
|
Sign up to set email alerts
|

Primary Dysmenorrhea in Relation to Oxidative Stress and Antioxidant Status: A Systematic Review of Case-Control Studies

Abstract: Primary dysmenorrhea is defined as painful menstrual cramps of uterine origin in the absence of pelvic pathology and is the most common gynecological disorder among women of reproductive age. The aim of this study was to systematically review case-control studies that have investigated the oxidative stress, antioxidant status, and inflammation markers among women with primary dysmenorrhea and controls. The study protocol was registered with PROSPERO (no. CRD42020183104). By searching PubMed and Scopus database… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(32 citation statements)
references
References 62 publications
1
25
0
Order By: Relevance
“…In another study, PMS women had a statistically significantly elevated DNA damage marker (urine 8-hydroxy-2-deoxyguanosine) compared to controls [ 34 ]. A higher level of oxidative stress occurs also in another menstrual cycle abnormality—primary dysmenorrhea, which was especially evident for lipid peroxidation markers [ 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…In another study, PMS women had a statistically significantly elevated DNA damage marker (urine 8-hydroxy-2-deoxyguanosine) compared to controls [ 34 ]. A higher level of oxidative stress occurs also in another menstrual cycle abnormality—primary dysmenorrhea, which was especially evident for lipid peroxidation markers [ 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…Prostaglandins lead to excessive contractile activity of the uterus, with the consequent hypoxia and pain [2]. In addition to prostaglandins, markers of inflammation and oxidative stress participate in the pathomechanism of dysmenorrhea [3,8].…”
Section: Introductionmentioning
confidence: 99%
“…Increased PGs cause hypercontractility and hypoxia of uterine smooth muscle with decreased uterine blood flow and elevated sensitivity of peripheral nerves to pain [14]. Multiple factors such as vasopressin, oxytocin, calcium, oxidative stress, inflammation, and nitric oxide have also been implicated in the mechanism [15][16][17]. Currently, non-steroidal anti-inflammatory drugs (NSAIDs) are considered the first-line treatment for dysmenorrhea; however, they are ineffective for or intolerable by approximately 15% of patients and may cause gastrointestinal and neurological adverse effects and a higher risk of severe cardiovascular disease with long-term usage [18,19].…”
Section: Introductionmentioning
confidence: 99%